Frontiers in Neuroscience | Neuropharmacology

Original Research

Published on 15 Sep 2023

Associations between psychotropic drugs and rsEEG connectivity and network characteristics: a cross-sectional study in hospital-admitted psychiatric patients

in Neuropharmacology

Melissa G. Zandstra
Hannah Meijs
Metten Somers
Cornelis J. Stam
Bieke de Wilde
Jan van Hecke
Peter Niemegeers
Jurjen J. Luykx
Edwin van Dellen

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1176825

3,003 views
1 citation

Original Research

Published on 15 Sep 2023

Accelerated differentiation of human induced pluripotent stem cells into regionally specific dorsal and ventral spinal neural progenitor cells for application in spinal cord therapeutics

in Neuropharmacology

Anne Huntemer-Silveira
Dane Malone
Anna Frie
Patrick Walsh
Ann M. Parr

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1251906

3,772 views
4 citations

Original Research

Published on 13 Sep 2023

A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT1A receptor antagonist and SSRI in rats

in Neuropharmacology

Jocelien D. A. Olivier
Josien A. Janssen
Diana C. Esquivel-Franco
Stephen de Prêtre
Berend Olivier

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1224959

15,985 views
2 citations

Systematic Review

Published on 12 Sep 2023

Neuroprotective effects of crude extracts, compounds, and isolated molecules obtained from plants in the central nervous system injuries: a systematic review

in Neuropharmacology

Maria Vitoria Nava Moura
Gabriel Mesquita da Conceição Bahia
Marcio Gonçalves Correa
Maíza Amanda Araujo Sarges
Thaís Alves Lobão
Erica Miranda Sanches
Karen R. H. Matos Oliveira
Anderson Manoel Herculano
Carlomagno Pacheco Bahia

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1249685

4,757 views
8 citations

Study Protocol

Published on 07 Sep 2023

Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201)

in Neuropharmacology

Chiara Pane
Alberto Maria Marra
Ludovica Aliberti
Mario Campanile
Federica Coscetta
Giulia Crisci
Roberta D'Assante
Angela Marsili
Giorgia Puorro
Andrea Salzano

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1260977

5,994 views
12 citations

Editorial

Published on 04 Sep 2023

Editorial: Neuropharmacological and neurotoxicological advances using in vivo non-mammalian model organisms

in Neuropharmacology

Lijie Xia
Meng Jin

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1264745

1,593 views
1 citation

Editorial

Published on 01 Sep 2023

Editorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action

in Neuropharmacology

Hiram Tendilla-Beltrán
David Martín-Hernández

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1278748

1,950 views

Brief Research Report

Published on 30 Aug 2023

Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats

in Neuropharmacology

Ashutosh Tripathi
Henry A. Nasrallah
Anilkumar Pillai

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1237726

3,247 views
5 citations

Brief Research Report

Published on 24 Aug 2023

Anti-epileptogenic effect of FC99 and resveratrol

in Neuropharmacology

Oded Shor
Roy Rabinowitz
Nir Hersh
Alexey Vanichkin
Felix Benninger

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1223196

2,164 views
3 citations

Review

Published on 17 Aug 2023

The immunomodulatory effect of lithium as a mechanism of action in bipolar disorder

in Neuropharmacology

Łukasz P. Szałach
Katarzyna A. Lisowska
Wiesław J. Cubała
Margherita Barbuti
Giulio Perugi

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1213766

10,128 views
13 citations

Review

Published on 08 Aug 2023

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

in Neuropharmacology

August P. M. Lullau
Emily M. W. Haga
Eivind H. Ronold
Gerard E. Dwyer

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1223145

11,850 views
53 citations

Editorial

Published on 08 Aug 2023

Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery

in Neuropharmacology

Chuipu Cai
Jiansong Fang
Hanzhong Ke

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1268710

2,959 views
4 citations

Review

Published on 07 Aug 2023

The emerging role of copper in depression

in Neuropharmacology

Jinhua Chen
Wenping Song
Wenzhou Zhang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1230404

15,995 views
18 citations

Original Research

Published on 03 Aug 2023

A brief exposure to toluene vapor alters the intrinsic excitability of D2 medium spiny neurons in the rat ventral striatum

in Neuropharmacology

Michael Okas
Abigail Kastner
Dominic Gioia
John J. Woodward

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1235866

2,026 views
2 citations

Review

Published on 01 Aug 2023

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder

in Neuropharmacology

Rodrigo Machado-Vieira
Alan C. Courtes
Carlos A. Zarate
Ioline D. Henter
Husseini K. Manji

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1228455

10,368 views
11 citations

Original Research

Published on 28 Jul 2023

Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions

in Neuropharmacology

Daniela Vázquez-González
Juan Carlos Corona

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1186520

3,276 views
8 citations

Mini Review

Published on 24 Jul 2023

Attenuation of ferroptosis as a potential therapeutic target for neuropsychiatric manifestations of post-COVID syndrome

in Neuropharmacology

Ricardo A. L. Sousa
Asmaa Yehia
Osama A. Abulseoud

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1237153

4,021 views
13 citations

Editorial

Published on 21 Jul 2023

Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies

in Neuropharmacology

Erxi Wu
Ronghu Ke
Dan Qi
Jason H. Huang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1254881

1,818 views
2 citations

Editorial

Published on 18 Jul 2023

Editorial: What does it take to cure the brain? Studies toward genes, proteins, processes, and rehabilitation

in Neuropharmacology

Xinhua Shu
Nunzio Denora
Valentino Laquintana

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1252955

1,380 views

Systematic Review

Published on 14 Jul 2023

The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature

in Neuropharmacology

Steven McGuigan
Daniel J. Marie
Liam J. O'Bryan
Francisco J. Flores
Lisbeth Evered
Brendan Silbert
David A. Scott

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1225191

6,566 views
13 citations

Review

Published on 13 Jul 2023

Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea

in Neuropharmacology

Piotr Kaczmarski
Marcin Sochal
Dominik Strzelecki
Piotr Białasiewicz
Agata Gabryelska

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1213971

16,446 views
39 citations

Original Research

Published on 11 Jul 2023

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder

in Neuropharmacology

Maria Gałuszko-Wȩgielnik
Katarzyna Jakuszkowiak-Wojten
Mariusz Stanisław Wiglusz
Wiesław Jerzy Cubała
Michał Pastuszak

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1214972

3,451 views
6 citations

Editorial

Published on 07 Jul 2023

Editorial: Innovative treatments for neuro-psychiatric diseases

in Neuropharmacology

Lucia Gozzo
Edoardo Spina
Filippo Drago

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1247681

2,057 views
1 citation

Original Research

Published on 30 Jun 2023

In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression

in Neuropharmacology

José Ramón Gutiérrez-Casares
Cristina Segú-Vergés
Juncal Sabate Chueca
Tamara Pozo-Rubio
Mireia Coma
Carmen Montoto
Javier Quintero

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1118253

6,522 views
3 citations

1,063 articles

articles

Associations between psychotropic drugs and rsEEG connectivity and network characteristics: a cross-sectional study in hospital-admitted psychiatric patients

Accelerated differentiation of human induced pluripotent stem cells into regionally specific dorsal and ventral spinal neural progenitor cells for application in spinal cord therapeutics

A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT1A receptor antagonist and SSRI in rats

Neuroprotective effects of crude extracts, compounds, and isolated molecules obtained from plants in the central nervous system injuries: a systematic review

Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201)

Editorial: Neuropharmacological and neurotoxicological advances using in vivo non-mammalian model organisms

Editorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action

Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats

Anti-epileptogenic effect of FC99 and resveratrol

The immunomodulatory effect of lithium as a mechanism of action in bipolar disorder

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery

The emerging role of copper in depression

A brief exposure to toluene vapor alters the intrinsic excitability of D2 medium spiny neurons in the rat ventral striatum

Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder

Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions

Attenuation of ferroptosis as a potential therapeutic target for neuropsychiatric manifestations of post-COVID syndrome

Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies

Editorial: What does it take to cure the brain? Studies toward genes, proteins, processes, and rehabilitation

The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature

Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder

Editorial: Innovative treatments for neuro-psychiatric diseases

In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression